Creo Medical Group PLC Overview
Pro stress-test →Creo Medical Group is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. The company designs and manufactures medical devices for surgical endoscopy applications across gastroenterology, urology, pulmonology, and surgery, leveraging its proprietary Kamaptive Technology platform.
Strategic Profile
Pro stress-test →The company has strengthened its competitive position through strategic acquisitions of Albyn Medical, Boucart Medical, and Endotechnik, providing established European distribution networks and a wider product portfolio. Creo Medical is pursuing international expansion and commercialization of its core advanced energy technology, positioning itself at the forefront of the therapeutic endoscopy market shift away from traditional surgical interventions.
Competitive Landscape
Pro stress-test →Creo Medical competes in the surgical endoscopy and minimally invasive devices market against larger medtech players offering electrosurgical platforms and endoscopic tools. The company differentiates through its proprietary Kamaptive Technology and focus on advanced energy delivery in therapeutic endoscopy, a rapidly growing segment as hospitals shift from traditional surgical to endoscopic interventions.
Industry Context
Creo Medical Group PLC operates in Medical Devices - Surgical Endoscopy and Minimally Invasive Surgery.
Key facts
Founded: 2003 · Headquarters: Chepstow, Wales, UK